X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36043) 36043
Magazine Article (254) 254
Newspaper Article (51) 51
Newsletter (34) 34
Book Chapter (15) 15
Transcript (14) 14
Publication (2) 2
Book Review (1) 1
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34047) 34047
prednisone - therapeutic use (24233) 24233
male (20633) 20633
female (19602) 19602
adult (13930) 13930
middle aged (13696) 13696
aged (9174) 9174
prednisone - administration & dosage (7995) 7995
antineoplastic combined chemotherapy protocols - therapeutic use (7680) 7680
adolescent (6288) 6288
prednisone (5966) 5966
treatment outcome (5474) 5474
child (5200) 5200
oncology (4489) 4489
vincristine - administration & dosage (4415) 4415
cyclophosphamide - therapeutic use (4377) 4377
drug therapy, combination (4149) 4149
cyclophosphamide - administration & dosage (4065) 4065
vincristine - therapeutic use (3550) 3550
prognosis (3425) 3425
immunosuppressive agents - therapeutic use (3373) 3373
doxorubicin - administration & dosage (3344) 3344
follow-up studies (3115) 3115
chemotherapy (3091) 3091
glucocorticoids - therapeutic use (3081) 3081
child, preschool (3072) 3072
hematology (3022) 3022
anti-inflammatory agents - therapeutic use (2820) 2820
retrospective studies (2816) 2816
prednisone - adverse effects (2756) 2756
time factors (2703) 2703
azathioprine - therapeutic use (2696) 2696
therapy (2682) 2682
aged, 80 and over (2415) 2415
medicine, general & internal (2324) 2324
corticosteroids (2264) 2264
doxorubicin - therapeutic use (2199) 2199
combined modality therapy (2155) 2155
biopsy (2063) 2063
diagnosis, differential (2014) 2014
antineoplastic combined chemotherapy protocols - administration & dosage (1889) 1889
infant (1885) 1885
remission induction (1879) 1879
cancer (1860) 1860
recurrence (1812) 1812
care and treatment (1770) 1770
transplantation (1746) 1746
antineoplastic agents - therapeutic use (1734) 1734
antineoplastic combined chemotherapy protocols - adverse effects (1734) 1734
rituximab (1680) 1680
prospective studies (1523) 1523
animals (1500) 1500
rheumatology (1495) 1495
drug administration schedule (1484) 1484
pediatrics (1481) 1481
methotrexate - therapeutic use (1472) 1472
surgery (1451) 1451
survival (1428) 1428
immunology (1422) 1422
lymphoma, large b-cell, diffuse - drug therapy (1412) 1412
lymphoma, non-hodgkin - drug therapy (1394) 1394
drug therapy (1376) 1376
disease (1374) 1374
survival rate (1369) 1369
prostate cancer (1356) 1356
cyclophosphamide (1351) 1351
neoplasm staging (1347) 1347
disease-free survival (1339) 1339
hodgkin disease - drug therapy (1332) 1332
urology & nephrology (1330) 1330
risk factors (1315) 1315
survival analysis (1292) 1292
clinical trials as topic (1224) 1224
methotrexate - administration & dosage (1215) 1215
young adult (1205) 1205
medicine & public health (1197) 1197
kidney transplantation (1176) 1176
diagnosis (1116) 1116
children (1113) 1113
docetaxel (1106) 1106
cyclosporine - therapeutic use (1100) 1100
adrenal cortex hormones - therapeutic use (1052) 1052
trial (1052) 1052
administration, oral (1033) 1033
bleomycin - administration & dosage (1026) 1026
cyclophosphamide - adverse effects (1022) 1022
methylprednisolone - therapeutic use (1019) 1019
tomography, x-ray computed (1019) 1019
multiple myeloma - drug therapy (1003) 1003
acute disease (992) 992
vincristine - adverse effects (991) 991
dose-response relationship, drug (987) 987
procarbazine - administration & dosage (984) 984
lymphomas (961) 961
patients (953) 953
prostatic neoplasms - drug therapy (952) 952
chronic disease (928) 928
research (920) 920
immunosuppression (916) 916
health aspects (914) 914
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30529) 30529
German (1512) 1512
French (1415) 1415
Spanish (904) 904
Italian (552) 552
Polish (486) 486
Chinese (443) 443
Japanese (369) 369
Portuguese (180) 180
Dutch (169) 169
Russian (148) 148
Romanian (93) 93
Czech (91) 91
Danish (88) 88
Norwegian (51) 51
Hebrew (38) 38
Serbian (28) 28
Hungarian (26) 26
Slovak (26) 26
Finnish (14) 14
Croatian (13) 13
Swedish (11) 11
Bulgarian (7) 7
Afrikaans (3) 3
Korean (3) 3
Ukrainian (3) 3
Bosnian (2) 2
Lithuanian (2) 2
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, Volume 6, Issue 2, 11
.... Since there are almost no randomized, controlled, double-blind studies comparing the use of various therapeutic agents in this condition, treatment decisions still rely heavily on individual clinicians experience... 
Methotrexate, therapeutic use | Mitomycin, therapeutic use | Tetracyclines, therapeutic use | Sulfasalazine, therapeutic use | Tacrolimus, therapeutic use | Nicotinamide, therapeutic use | Cyclophosphamide, therapeutic use | Mycophenolate mofetil, therapeutic use | Pemphigoid, treatment | Calcineurin inhibitors, therapeutic use | Azathioprine, therapeutic use | Leflunomide, therapeutic use | Immunoglobulins, therapeutic use | Interferon alpha 2b, therapeutic use | Corticosteroids, therapeutic use | Sulfapyridine, therapeutic use | Sulfamethoxypyridazine, therapeutic use | Thalidomide, therapeutic use | Ciclosporin, therapeutic use | Prednisone, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | PLASMA-EXCHANGE | IMMUNOSUPPRESSIVE THERAPY | TOPICAL CYCLOSPORINE | MITOMYCIN-C | PASSIVE TRANSFER | INTRAVENOUS IMMUNOGLOBULIN THERAPY | SYSTEMIC CHEMOTHERAPY | THALIDOMIDE THERAPY | NECROSIS-FACTOR-ALPHA | MYCOPHENOLATE-MOFETIL | DERMATOLOGY | Calcineurin Inhibitors | Pemphigoid, Benign Mucous Membrane - therapy | Antibiotics, Antineoplastic - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Mitomycin - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Administration, Topical | Tetracyclines - therapeutic use | Plasmapheresis
Book Review
European Urology, ISSN 0302-2838, 2011, Volume 61, Issue 5, pp. 950 - 960
...) progression has led to the recognition of multiple molecular targets and advances in the therapeutic landscape... 
Urology | Molecular targets | Chemotherapy | Immunotherapy | Androgen pathway inhibitors | Biologic agents | Androgen receptor | Prostate cancer | Skeletal-related events | ADVANCED SOLID TUMORS | DOCETAXEL | PATHWAY ACTIVATION | MITOXANTRONE PLUS PREDNISONE | INHIBITION | RANDOMIZED PHASE-II | CLINICAL-TRIALS | UROLOGY & NEPHROLOGY | END-POINTS | HIGH-DOSE CALCITRIOL | Receptors, Vascular Endothelial Growth Factor | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Ipilimumab | Recombinant Fusion Proteins - therapeutic use | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Thiazoles - therapeutic use | Abiraterone Acetate | Quinolones | Antibodies, Monoclonal, Humanized | Taxoids - therapeutic use | Cancer Vaccines - therapeutic use | Clinical Trials, Phase III as Topic | Bone Neoplasms - drug therapy | Clusterin - therapeutic use | Prostatic Neoplasms - drug therapy | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Dasatinib | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Carcinoma - surgery | Treatment Outcome | Vaccines, Synthetic - therapeutic use | Tissue Extracts - therapeutic use | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Pyrimidines - therapeutic use | Androstadienes - therapeutic use | Quinolines - therapeutic use | Medical colleges | Hospitals | Development and progression | Metastasis | Tubulins | Cancer | Landscape | Conferences | Immunoregulation | Clinical trials | Data processing | Oncology | Src protein | Clusterin | Metastases | Angiogenesis | Signal transduction | Androgens | Antagonism | Databases | Reviews | Tubulin | Acetic acid
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Journal Article
Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 6, p. CD003725
...), and strength at two years (two‐year data on function are very limited). Corticosteroids, now part of care recommendations for DMD, are largely in routine use, although... 
Muscle Diseases | Pregnenediones | Glucocorticoids | Adrenal Cortex Hormones | Prednisone | Randomized Controlled Trials as Topic | Walking | Neurology | Duchenne muscular dystrophy | Child health | Quality of Life | Muscular dystrophies | Muscle disease | Muscular Dystrophy, Duchenne | Medicine General & Introductory Medical Sciences | Muscle Strength | Prednisolone | Corticosteroid treatment | AMERICAN ACADEMY | CONTROLLED-TRIAL | LOW-DOSAGE | Humans | Male | Adrenal Cortex Hormones [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [adverse effects; therapeutic use] | PREDNISONE TREATMENT | Prednisolone [therapeutic use] | Prednisone [therapeutic use] | DEFLAZACORT TREATMENT | GLYCOPROTEIN COMPLEX | DOUBLE-BLIND | Muscular Dystrophy, Duchenne [drug therapy] | MOLECULAR PATHOGENESIS | Pregnenediones [therapeutic use] | STEROID-THERAPY | LONG-TERM TREATMENT | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Muscular Dystrophy, Duchenne - drug therapy | Pregnenediones - administration & dosage | Adrenal Cortex Hormones - therapeutic use | Pregnenediones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Muscle Strength - drug effects | Prednisolone - therapeutic use | Glucocorticoids - adverse effects | Prednisone - therapeutic use | Adrenal Cortex Hormones - administration & dosage
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 10, p. CD001446
Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be... 
Guillain‐Barre Syndrome | Glucocorticoids | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Child health | Guillain‐Barré syndrome | Anti‐Inflammatory Agents | Adrenocorticotropic Hormone | Medicine General & Introductory Medical Sciences | Prednisolone | Corticosteroid treatment | GLOMERULONEPHRITIS | Methylprednisolone [administration & dosage; therapeutic use] | STEROIDS | Humans | Prednisolone [administration & dosage; therapeutic use] | Adrenocorticotropic Hormone [administration & dosage;therapeutic use] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | METHYLPREDNISOLONE | Guillain-Barre Syndrome [drug therapy] | TRIAL | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | PREDNISONE | THERAPY | STANDARD TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | Anti-Inflammatory Agents [administration & dosage;therapeutic use] | Adult | Glucocorticoids [administration & dosage; therapeutic use] | Child | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisolone - administration & dosage | Methylprednisolone - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Guillain-Barre Syndrome - drug therapy | Adrenocorticotropic Hormone - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisolone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
Drugs & Aging, ISSN 1170-229X, 2003, Volume 20, Issue 1, pp. 23 - 57
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, pp. CD010369 - CD010369
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic progressive or relapsing and remitting disease that usually causes... 
Immunoglobulin treatment | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Dexamethasone | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Adrenal Cortex Hormones | Interferon beta‐1a | Prednisone | Immunosuppressive and immunomodulatory treatment | Plasma Exchange | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Plasma exchange treatment | Neurology | Review Literature as Topic | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Corticosteroid treatment | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | NEUROMUSCULAR DISORDERS | MULTIPLE-SCLEROSIS | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | INTEROBSERVER AGREEMENT | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | METHODOLOGICAL QUALITY | TECHNOLOGY-ASSESSMENT SUBCOMMITTEE | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Prednisone - therapeutic use | Index Medicus
Journal Article